- Home
- PVLA vs PMTS Comparison
PVLA vs PMTS Comparison
Compare PVLA & PMTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVLA
- PMTS
- Stock Information
- Founded
- PVLA 2015
- PMTS 2007
- Country
- PVLA United States
- PMTS United States
- Employees
- PVLA N/A
- PMTS N/A
- Industry
- PVLA Biotechnology: Pharmaceutical Preparations
- PMTS Finance Companies
- Sector
- PVLA Health Care
- PMTS Finance
- Exchange
- PVLA Nasdaq
- PMTS Nasdaq
- Market Cap
- PVLA 308.2M
- PMTS 327.9M
- IPO Year
- PVLA N/A
- PMTS 2015
- Fundamental
- Price
- PVLA $24.36
- PMTS $25.24
- Analyst Decision
- PVLA Strong Buy
- PMTS Strong Buy
- Analyst Count
- PVLA 7
- PMTS 4
- Target Price
- PVLA $44.43
- PMTS $37.25
- AVG Volume (30 Days)
- PVLA 97.9K
- PMTS 36.0K
- Earning Date
- PVLA 05-15-2025
- PMTS 05-06-2025
- Dividend Yield
- PVLA N/A
- PMTS N/A
- EPS Growth
- PVLA N/A
- PMTS N/A
- EPS
- PVLA N/A
- PMTS 1.64
- Revenue
- PVLA N/A
- PMTS $480,601,000.00
- Revenue This Year
- PVLA N/A
- PMTS $9.69
- Revenue Next Year
- PVLA N/A
- PMTS $6.30
- P/E Ratio
- PVLA N/A
- PMTS $15.39
- Revenue Growth
- PVLA N/A
- PMTS 8.11
- 52 Week Low
- PVLA $6.20
- PMTS $16.08
- 52 Week High
- PVLA $29.27
- PMTS $35.19
- Technical
- Relative Strength Index (RSI)
- PVLA N/A
- PMTS 42.69
- Support Level
- PVLA N/A
- PMTS $24.16
- Resistance Level
- PVLA N/A
- PMTS $26.91
- Average True Range (ATR)
- PVLA 0.00
- PMTS 2.05
- MACD
- PVLA 0.00
- PMTS -0.06
- Stochastic Oscillator
- PVLA 0.00
- PMTS 45.10
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. It is developing a broad pipeline of product candidates based on its patented QTORIN platform, with an initial focus on serious, rare genetic skin diseases. Palvella's lead product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations (microcystic LMs) and cutaneous venous malformations.
About PMTS CPI Card Group Inc.
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit, which produces Financial Payment Cards and provides integrated card services to card-issuing banks in the United States, and Prepaid Debit, which provides integrated card services to Prepaid Debit Card program managers in the United States and Others. It derives key revenue from the Debit and Credit segment.